Arecor Therapeutics PLC
Activities of other holding companies n.e.c. · Saffron Walden
ActiveUnited KingdomIncorporated 2021Public Limited Company
Ownership evidence
Reported ownership and control rights in this business, with source dates.
Reported ownership & control
0 without an end date · 1 ceasedNo control records without an end date are available. This alone does not establish who owns or controls the company.
Show 1 ceased record
SH
Sarah HowellIndividual
Shares: over 75%, up to 100%Voting rights: over 75%, up to 100%Right to appoint or remove directors
Notified 2021-04-13 · Ceased 2021-05-24
Source record 132849979People behind the business
Current appointments and the wider business interests of each person.
Appointments
7 current · 7 historicalSO
Simon John OrmistonCurrent director
Appointed 2025-09-29 · 1 yr · Director
DE
David John EllamCurrent director
Appointed 2025-09-29 · 1 yr · Cfo
DE
David EllamCurrent secretary
Appointed 2024-12-19 · 1 yr
JM
Jeremy MorganCurrent director
Appointed 2021-05-25 · 5 yrs · Director
AR
Andrew RichardsCurrent director
Appointed 2021-04-13 · 5 yrs · Director
MF+1 other
Mohammad FazeliCurrent director
Appointed 2021-04-13 · 5 yrs · Senior Pharmaceutical Analyst
Show 7 historical appointments
CS
Christine SodenResigned director
Resigned 2021-05-25 · 4 yrs · Director
SD
Resigned 2021-04-13 · 3 yrs
JC
Jeremy Curnock CookResigned director
Resigned 2021-04-13 · Investment Director
AC
Alexander CrawfordResigned director
Resigned 2021-04-13 · Investment Manager
AL
Andrew LaneResigned director
Resigned 2021-04-13 · Director
AS
Alan SmithResigned director
Resigned 2021-04-13 · 4 yrs · Director
Board profile
- People with appointments
- 7
- Directors assessed
- 6
- Median age
- 62
- Under 35
- 0
- 65 and over
- 1
- Disqualified match
- None active